Results 241 to 250 of about 381,827 (331)
12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes-2026. [PDF]
American Diabetes Association Professional Practice Committee for Diabetes* .
europepmc +1 more source
[Use and abuse of the prescription of anti-ulcer agents].
J L, Zambrana García +1 more
openaire +1 more source
ABSTRACT Background Lichen sclerosus is a chronic, inflammatory, scarring disease of the skin that manifests mostly in the genital region. Objective We studied the histomorphological characteristics, grade, and pattern of inflammation in male pediatric patients with lichen sclerosus.
Valerie Flammang +10 more
wiley +1 more source
Effectiveness of a formulary system on prophylactic oral proton pump inhibitors for drug-induced peptic ulcer in a Japanese tertiary hospital: an interrupted time series analysis. [PDF]
Ishida R +9 more
europepmc +1 more source
This illustration summarises our primary findings highlighting the rising incidence of certain extra‐digestive cancers among persons with IBD over the 25‐year study duration (left), and the relative rates of extra‐digestive cancer incidence and mortality among persons with IBD in recent years (2010–2019) compared to their age‐ and sex‐matched controls (
Sanjay K. Murthy +13 more
wiley +1 more source
Macau as Method: Recombinant Urbanism in Post‐Socialist China
ABSTRACT In ‘Asia as Method’, Chen Kuan‐Hsing argues for the value of an indigenous inter‐Asian approach to analysing the effects of European imperialism on the countries and citizens of Asia. This article mobilises both Chen's inter‐Asian referencing strategy and the city‐state of Macau to explore Macau's role in China's engagements with global ...
Tim Simpson
wiley +1 more source
Clinical efficacy of <i>Psidium guajava</i> - based Herbal gel in the management of recurrent aphthous stomatitis: A randomized clinical trial. [PDF]
Mansoor E +3 more
europepmc +1 more source
Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen +3 more
wiley +1 more source

